- Home
- CAPR vs CCRN Comparison
CAPR vs CCRN Comparison
Compare CAPR & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- CCRN
- Stock Information
- Founded
- CAPR 2005
- CCRN 1986
- Country
- CAPR United States
- CCRN United States
- Employees
- CAPR N/A
- CCRN N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- CCRN Professional Services
- Sector
- CAPR Health Care
- CCRN Consumer Discretionary
- Exchange
- CAPR Nasdaq
- CCRN Nasdaq
- Market Cap
- CAPR 622.9M
- CCRN 586.8M
- IPO Year
- CAPR N/A
- CCRN N/A
- Fundamental
- Price
- CAPR $12.79
- CCRN $15.76
- Analyst Decision
- CAPR Strong Buy
- CCRN Buy
- Analyst Count
- CAPR 7
- CCRN 4
- Target Price
- CAPR $39.29
- CCRN $18.31
- AVG Volume (30 Days)
- CAPR 1.5M
- CCRN 619.5K
- Earning Date
- CAPR 03-19-2025
- CCRN 03-05-2025
- Dividend Yield
- CAPR N/A
- CCRN N/A
- EPS Growth
- CAPR N/A
- CCRN N/A
- EPS
- CAPR N/A
- CCRN N/A
- Revenue
- CAPR $23,228,045.00
- CCRN $1,344,004,000.00
- Revenue This Year
- CAPR N/A
- CCRN N/A
- Revenue Next Year
- CAPR $74.85
- CCRN $3.21
- P/E Ratio
- CAPR N/A
- CCRN N/A
- Revenue Growth
- CAPR 65.33
- CCRN N/A
- 52 Week Low
- CAPR $3.52
- CCRN $9.58
- 52 Week High
- CAPR $23.40
- CCRN $19.25
- Technical
- Relative Strength Index (RSI)
- CAPR 42.76
- CCRN 16.95
- Support Level
- CAPR $11.75
- CCRN $15.76
- Resistance Level
- CAPR $16.17
- CCRN $16.18
- Average True Range (ATR)
- CAPR 1.51
- CCRN 0.30
- MACD
- CAPR -0.18
- CCRN -0.16
- Stochastic Oscillator
- CAPR 22.96
- CCRN 10.26
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.